Literature DB >> 25708628

Biomedical studies by TOF-SIMS imaging.

Claudia Bich1, David Touboul1, Alain Brunelle1.   

Abstract

Imaging by secondary ion mass spectrometry coupled to time-of-flight mass analysis (TOF-SIMS) is a method of which the applications have greatly increased since 10 years. Taking advantage of the development of cluster ion sources, TOF-SIMS offers images of molecular ions at a micrometer lateral resolution or slightly below and does not require complex sample preparation. Although TOF-SIMS has been primarily dedicated to surface analysis of inorganic or polymeric samples, several groups have successfully demonstrated that TOF-SIMS imaging is also perfectly suited for mapping organic compounds, such as drugs or lipids, directly on tissue sections from animals or from human biopsies. This minireview will enlighten some of these developments in the field of biomedical applications.

Entities:  

Mesh:

Year:  2014        PMID: 25708628     DOI: 10.1116/1.4901511

Source DB:  PubMed          Journal:  Biointerphases        ISSN: 1559-4106            Impact factor:   2.456


  3 in total

1.  Characterization of foreign materials in paraffin-embedded pathological specimens using in situ multi-elemental imaging with laser spectroscopy.

Authors:  Benoit Busser; Samuel Moncayo; Florian Trichard; Vincent Bonneterre; Nicole Pinel; Frédéric Pelascini; Philippe Dugourd; Jean-Luc Coll; Michel D'Incan; Julie Charles; Vincent Motto-Ros; Lucie Sancey
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

2.  Analysis and imaging of biocidal agrochemicals using ToF-SIMS.

Authors:  Valerio Converso; Sarah Fearn; Ecaterina Ware; David S McPhail; Anthony J Flemming; Jacob G Bundy
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

3.  Microneedle-Mediated Permeation Enhancement of Chlorhexidine Digluconate: Mechanistic Insights Through Imaging Mass Spectrometry.

Authors:  Melissa Kirkby; Akmal Bin Sabri; David Scurr; Gary Moss
Journal:  Pharm Res       Date:  2022-06-10       Impact factor: 4.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.